High materiality7/10
First Tracks Biotherapeutics price target raised to $62 from $55 at Wells Fargo
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
PT raised to $62; current price $32.01; suggests meaningful upside potential.
- PT raised to 62; current price 32.01.
Key facts
- 01
Target: $62
- 02
Posted price: $32.01
- 03
Analyst firm: Wells Fargo
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.